EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring in clinical practice: the spanish cohort of the COMORA study

Alejandro Balsa, Leticia Lojo-Oliveira, Mercedes Alperi-López, María García-Manrique, Carmen Ordóñez-Cañizares, Lorena Pérez, Virginia Ruiz-Esquide, Alfonso Corrales, Javier Narváez, José Rey-Rey, Carlos Rodríguez-Lozano, Soledad Ojeda und 20 weitere

Reumatología Clínica · 2019-03 · 15 (2) · 102-108

DOI: 10.1016/j.reuma.2017.06.002 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Reumatología Clínica, 2019-03. Verfasst von Alejandro Balsa und 31 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Universitario La Paz IdiPAZ, Madrid, Spain. Electronic address: alejandro.balsa@salud.madrid.org. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Roche España.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: To describe the prevalence of comorbidities in patients with RA in Spain and discuss their management and implications using data from the Spanish cohort of the multinational study on COMOrbidities in Rheumatoid Arthritis (COMORA). METHODS: This is a national sub-analysis of the COMORA study. We studied the demographics and disease characteristics of 200 adults patients diagnosed with RA (1987 ACR), and routine practices for screening and preventing the following selected comorbidities: cardiovascular, infections, cancer, gastrointestinal, pulmonary, osteoporosis and depression. RESULTS: Patients had a mean age of 58 years and a mean RA duration of 10 years. Mean DAS28 score was 3.3 and approximately 25% of patients were in remission (DAS28 20% (51%), hypercholesterolemia (46%) or hypertension (41%) and smoking (25%) were the most common CV risk factors. For prostate, colon and skin cancers, only 9%, 10% and 18% of patients, respectively, were optimally monitored. Infections were also inadequately managed, with 7% and 17% of patients vaccinated against influenza and pneumococcal, respectively, as was osteoporosis, with 47% of patients supplemented with vitamin D and 56% with a bone densitometry performed. CONCLUSIONS: In Spain, the prevalence of comorbidities and CV risk factors in RA patients with established and advanced disease is relatively high, and their management in clinical daily practice remains suboptimal.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdolescentAdultAgedAged, 80 and overArthritis, RheumatoidComorbidityCross-Sectional StudiesFemaleHumansMaleMiddle AgedPrevalenceRisk FactorsSpainYoung Adult

Stichwörter der Autor:innen

Artritis reumatoideComorbiditiesComorbilidadesFactores de riesgoPrevalencePrevalenciaRheumatoid arthritisRisk factors

Autor:innen und Institutionen

  • Hospital Universitario La Paz IdiPAZ, Madrid, Spain. Electronic address: alejandro.balsa@salud.madrid.org.
  • Hospital Universitario La Paz IdiPAZ, Madrid, Spain.
  • Hospital Universitario Central de Asturias, Asturias, Spain.
  • Hospital Parc Taulí, Sabadell, Barcelona, Spain.
  • Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, Spain.
  • Hospital Universitario Infanta Sofía, Universidad Europea de Madrid, Madrid, Spain.

Förderung

  • Roche España

Zitieren

APA

Balsa, A., Lojo-Oliveira, L., Alperi-López, M., García-Manrique, M., Ordóñez-Cañizares, C., Pérez, L., Ruiz-Esquide, V., Corrales, A., Narváez, J., Rey-Rey, J., Rodríguez-Lozano, C., Ojeda, S., Muñoz-Fernández, S., Nolla, J. M., García-Torrón, J., Gamero, F., García-Vicuña, R., Hernández-Cruz, B., Campos, J., …, & Martín-Mola, E. (2019). Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring in clinical practice: the spanish cohort of the COMORA study. Reumatología Clínica, 15(2), 102-108. https://doi.org/10.1016/j.reuma.2017.06.002

Vancouver

Balsa A, Lojo-Oliveira L, Alperi-López M, García-Manrique M, Ordóñez-Cañizares C, Pérez L, et al. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring in clinical practice: the spanish cohort of the COMORA study. Reumatología Clínica. 2019;15(2):102-108. doi:10.1016/j.reuma.2017.06.002

BibTeX
@article{Balsa2019,
  author = {Balsa, Alejandro and Lojo-Oliveira, Leticia and Alperi-López, Mercedes and García-Manrique, María and Ordóñez-Cañizares, Carmen and Pérez, Lorena and Ruiz-Esquide, Virginia and Corrales, Alfonso and Narváez, Javier and Rey-Rey, José and Rodríguez-Lozano, Carlos and Ojeda, Soledad and Muñoz-Fernández, Santiago and Nolla, Joan M and García-Torrón, José and Gamero, Fernando and García-Vicuña, Rosario and Hernández-Cruz, Blanca and Campos, José and Rosas, José and García-Llorente, José Francisco and Gómez-Centeno, Antonio and Cáliz, Rafael and Sanmartí, Raimon and Bermúdez, Alberto and Abasolo-Alcázar, Lydia and Fernández-Nebro, Antonio and Rodríguez-Rodríguez, Luis and Marras, Carlos and González-Gay, Miguel Ángel and Hmamouchi, Ihsane and Martín-Mola, Emilio},
  title = {Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring in clinical practice: the spanish cohort of the COMORA study},
  journal = {Reumatología Clínica},
  year = {2019},
  volume = {15},
  number = {2},
  pages = {102--108},
  doi = {10.1016/j.reuma.2017.06.002}
}
Kostenlos starten →